The University of Chicago Header Logo

Connection

Harvey M. Golomb to Humans

This is a "connection" page, showing publications Harvey M. Golomb has written about Humans.
Connection Strength

0.504
  1. Fifty years of hairy cell leukemia treatments. Leuk Lymphoma. 2011 Jun; 52 Suppl 2:3-5.
    View in: PubMed
    Score: 0.013
  2. Hairy cell leukemia: treatment successes in the past 25 years. J Clin Oncol. 2008 Jun 01; 26(16):2607-9.
    View in: PubMed
    Score: 0.011
  3. A phase II study of 9-aminocamptothecin in advanced non-small-cell lung cancer. Ann Oncol. 1998 Oct; 9(10):1085-90.
    View in: PubMed
    Score: 0.006
  4. Management of early-stage Hodgkin's disease: a continuing evolution. Semin Oncol. 1998 Aug; 25(4):476-82.
    View in: PubMed
    Score: 0.005
  5. Severe hemophagocytic lymphohistiocytosis in a melanoma patient treated with ipilimumab + nivolumab. J Immunother Cancer. 2018 07 16; 6(1):73.
    View in: PubMed
    Score: 0.005
  6. Ifosfamide-based three-drug combination regimens in non-small cell lung cancer. Semin Oncol. 1998 Feb; 25(1 Suppl 2):19-22.
    View in: PubMed
    Score: 0.005
  7. Paclitaxel/carboplatin plus ifosfamide in non-small cell lung cancer. Semin Oncol. 1997 Aug; 24(4 Suppl 12):S12-67-S12-69.
    View in: PubMed
    Score: 0.005
  8. Clinical studies of docetaxel (Taxotere) and concomitant chest therapy. Semin Oncol. 1997 Aug; 24(4 Suppl 14):S14-26-S14-29.
    View in: PubMed
    Score: 0.005
  9. Vinorelbine (Navelbine), cisplatin, and concomitant radiation therapy for advanced malignancies of the chest: a Phase I study. Semin Oncol. 1996 Apr; 23(2 Suppl 5):48-52.
    View in: PubMed
    Score: 0.005
  10. Familial myeloid leukemia associated with loss of the long arm of chromosome 5. Leukemia. 1996 Apr; 10(4):669-74.
    View in: PubMed
    Score: 0.005
  11. In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs. Mayo Clin Proc. 2015 Aug; 90(8):996-1000.
    View in: PubMed
    Score: 0.004
  12. Management of pulmonary metastases. Lancet. 1995 Jul 08; 346(8967):68.
    View in: PubMed
    Score: 0.004
  13. Randomized comparison of pentostatin versus interferon alfa-2a in previously untreated patients with hairy cell leukemia: an intergroup study. J Clin Oncol. 1995 Apr; 13(4):974-82.
    View in: PubMed
    Score: 0.004
  14. A phase I trial of concomitant chemoradiotherapy with cisplatin dose intensification and granulocyte-colony stimulating factor support for advanced malignancies of the chest. Cancer Chemother Pharmacol. 1995; 35(4):304-12.
    View in: PubMed
    Score: 0.004
  15. Pentostatin treatment for hairy cell leukemia patients who failed initial therapy with recombinant alpha-interferon: a report of CALGB study 8515. Leukemia. 1994 Dec; 8(12):2037-40.
    View in: PubMed
    Score: 0.004
  16. Do we know the treatment of choice for hairy cell leukemia? Ann Oncol. 1994 Oct; 5(8):676-7.
    View in: PubMed
    Score: 0.004
  17. A phase II study of cisplatin, 5-fluorouracil, and leucovorin augmented by vinorelbine (Navelbine) for advanced non-small cell lung cancer: rationale and study design. Semin Oncol. 1994 Oct; 21(5 Suppl 10):79-83; discussion 83-4.
    View in: PubMed
    Score: 0.004
  18. Concomitant chemoradiotherapy for non-small cell lung cancer. Lung Cancer. 1994 Mar; 10 Suppl 1:S253-61.
    View in: PubMed
    Score: 0.004
  19. Interferon treatment for hairy cell leukemia. An update on a cohort of 69 patients treated from 1983 to 1986. Leuk Lymphoma. 1994; 14 Suppl 1:89-93.
    View in: PubMed
    Score: 0.004
  20. Hairy cell leukaemia. Baillieres Clin Haematol. 1993 Dec; 6(4):887-98.
    View in: PubMed
    Score: 0.004
  21. Acute myeloid leukaemia following interferon-alfa treatment of hairy cell leukaemia. Br J Haematol. 1993 Mar; 83(3):519-20.
    View in: PubMed
    Score: 0.004
  22. Hairy cell leukemia 1992. Leukemia. 1992 Nov; 6 Suppl 4:142-6.
    View in: PubMed
    Score: 0.004
  23. Interferon treatment for hairy cell leukemia: an update on a cohort of 69 patients treated from 1983-1986. Leukemia. 1992 Nov; 6(11):1177-80.
    View in: PubMed
    Score: 0.004
  24. The impact on survival by adjuvant chemotherapy and radiation therapy in stage II non-small-cell lung cancer. Am J Clin Oncol. 1992 Oct; 15(5):405-11.
    View in: PubMed
    Score: 0.004
  25. Mechanism of interferon action in hairy cell leukemia: a model of effective cancer biotherapy. Cancer Res. 1992 Mar 01; 52(5):1056-66.
    View in: PubMed
    Score: 0.003
  26. The treatment of hairy cell leukemia: an update. Leukemia. 1992; 6 Suppl 2:24-7.
    View in: PubMed
    Score: 0.003
  27. Treatment options for hairy-cell leukemia. Semin Oncol. 1991 Oct; 18(5 Suppl 7):7-11.
    View in: PubMed
    Score: 0.003
  28. CD5+, CD11c+, CD20+ hairy cell leukemia. Blood. 1991 Apr 01; 77(7):1617-9.
    View in: PubMed
    Score: 0.003
  29. Role of systemic therapy in advanced non-small-cell lung cancer. Am J Med. 1990 Dec; 89(6):777-86.
    View in: PubMed
    Score: 0.003
  30. Serum soluble interleukin-2 receptor is associated with clinical and pathologic disease status in hairy cell leukemia. Blood. 1990 Nov 15; 76(10):1941-5.
    View in: PubMed
    Score: 0.003
  31. 5-Fluorouracil with oral leucovorin and hydroxyurea and concomitant radiotherapy for stage III non-small cell lung cancer. Cancer. 1990 Aug 01; 66(3):437-42.
    View in: PubMed
    Score: 0.003
  32. Sex-associated differences in presentation and survival in patients with lung cancer. J Clin Oncol. 1990 Aug; 8(8):1402-7.
    View in: PubMed
    Score: 0.003
  33. B-cell growth factor-induced and alpha-interferon-inhibited proliferation of hairy cells coincides with modulation of cell surface antigens. Cancer Res. 1990 Jul 01; 50(13):4111-20.
    View in: PubMed
    Score: 0.003
  34. Duration of response after interferon treatment of hairy cell leukemia. Blood. 1990 Jun 15; 75(12):2465-7.
    View in: PubMed
    Score: 0.003
  35. Hairy cell leukemia. Current management. Hematol Oncol Clin North Am. 1990 Apr; 4(2):489-502.
    View in: PubMed
    Score: 0.003
  36. Design of combination biotherapy studies: future goals and challenges. Semin Oncol. 1990 Feb; 17(1 Suppl 1):3-10; discussion 38-41.
    View in: PubMed
    Score: 0.003
  37. Long-term survival of patients with intermediate and high grade lymphoma treated with COMLA/ABP. Leukemia. 1990 Feb; 4(2):127-31.
    View in: PubMed
    Score: 0.003
  38. The staging of non-Hodgkin's lymphomas. Semin Oncol. 1990 Feb; 17(1):43-50.
    View in: PubMed
    Score: 0.003
  39. Efficacy of computed tomography of the thorax and upper abdomen and whole-body gallium scintigraphy for staging of lung cancer. Cancer. 1989 Oct 01; 64(7):1404-8.
    View in: PubMed
    Score: 0.003
  40. Low-dose interferon alfa-2b in the treatment of hairy cell leukemia. J Natl Cancer Inst. 1989 Aug 02; 81(15):1172-4.
    View in: PubMed
    Score: 0.003
  41. Is there a direct differentiation-inducing effect of human recombinant interferon on hairy cell leukemia in vitro? Cancer. 1989 Jul 15; 64(2):374-8.
    View in: PubMed
    Score: 0.003
  42. Neoadjuvant vindesine, etoposide, and cisplatin for locally advanced non-small cell lung cancer. Final report of a phase 2 study. Chest. 1989 Jul; 96(1):110-3.
    View in: PubMed
    Score: 0.003
  43. The staging of Hodgkin's disease. Hematol Oncol Clin North Am. 1989 Jun; 3(2):237-51.
    View in: PubMed
    Score: 0.003
  44. Cytogenetic abnormalities in a secondary lymphoma complicating cardiac transplantation. Leukemia. 1989 Apr; 3(4):303-4.
    View in: PubMed
    Score: 0.003
  45. What is the choice of treatment for hairy cell leukemia? J Clin Oncol. 1989 Feb; 7(2):156-8.
    View in: PubMed
    Score: 0.003
  46. High-dose, multiple-alkylator chemotherapy with autologous bone marrow reinfusion in patients with advanced non-small cell lung cancer. Cancer. 1989 Jan 15; 63(2):238-42.
    View in: PubMed
    Score: 0.003
  47. Prognostic variables in hairy cell leukemia after splenectomy as initial therapy. Cancer. 1988 Dec 01; 62(11):2420-4.
    View in: PubMed
    Score: 0.003
  48. Report of a multi-institutional study of 193 patients with hairy cell leukemia treated with interferon-alfa2b. Semin Oncol. 1988 Oct; 15(5 Suppl 5):7-9.
    View in: PubMed
    Score: 0.003
  49. Evaluation of Leu-M5 (CD11c) in hairy cell leukemia by the alkaline phosphatase anti-alkaline phosphatase technique. Am J Clin Pathol. 1988 Sep; 90(3):250-6.
    View in: PubMed
    Score: 0.003
  50. Modulation of the expression of major histocompatibility antigens on splenic hairy cells--differential effect upon in vitro treatment with alpha-2b-interferon, gamma-interferon, and interleukin-2. Blood. 1988 Sep; 72(3):1048-53.
    View in: PubMed
    Score: 0.003
  51. Skeletal complications in hairy cell leukemia: diagnosis and therapy. J Clin Oncol. 1988 Aug; 6(8):1280-4.
    View in: PubMed
    Score: 0.003
  52. Randomized study of the duration of treatment with interferon alfa-2B in patients with hairy cell leukemia. J Natl Cancer Inst. 1988 May 04; 80(5):369-73.
    View in: PubMed
    Score: 0.003
  53. Interferon-induced surface alterations in hairy cells. A review. Scanning Microsc. 1988 Mar; 2(1):485-92.
    View in: PubMed
    Score: 0.003
  54. Specific chromosomal abnormalities in acute nonlymphocytic leukemia correlate with drug susceptibility in vivo. Leukemia. 1988 Feb; 2(2):79-83.
    View in: PubMed
    Score: 0.003
  55. Ultrastructure of four human germ cell tumor-derived cell lines: effect of 12-O-tetradecanoyl phorbol-13-acetate. Cancer Invest. 1988; 6(4):393-402.
    View in: PubMed
    Score: 0.003
  56. Rapid response to 2'-deoxycoformycin in advanced hairy cell leukemia after failure of interferons alpha and gamma. Am J Hematol. 1988 Jan; 27(1):60-2.
    View in: PubMed
    Score: 0.003
  57. Flow cytometry in hairy cell leukemia before and during interferon alfa-2b therapy. Cancer. 1987 Jun 15; 59(12):1987-91.
    View in: PubMed
    Score: 0.003
  58. Prophylactic cranial irradiation in adenocarcinoma of the lung. A possible role. Cancer. 1987 Jun 15; 59(12):2016-9.
    View in: PubMed
    Score: 0.003
  59. Sequential evaluation of alpha-2b-interferon treatment in 128 patients with hairy cell leukemia. Semin Oncol. 1987 Jun; 14(2 Suppl 2):13-7.
    View in: PubMed
    Score: 0.003
  60. Recent advances in the treatment of hairy-cell leukemia. N Engl J Med. 1987 Apr 02; 316(14):870-2.
    View in: PubMed
    Score: 0.002
  61. Guidelines for the treatment of hairy cell leukemia. Leukemia. 1987 Apr; 1(4):405-6.
    View in: PubMed
    Score: 0.002
  62. The treatment of hairy cell leukemia. Blood. 1987 Apr; 69(4):979-83.
    View in: PubMed
    Score: 0.002
  63. Phase II study of carboplatin in previously untreated patients with metastatic small cell lung carcinoma. Cancer Treat Rep. 1987 Mar; 71(3):311-2.
    View in: PubMed
    Score: 0.002
  64. Gonadal and sexual function in male patients with hairy cell leukemia: lack of adverse effects of recombinant alpha 2-interferon treatment. Cancer Treat Rep. 1987 Feb; 71(2):179-81.
    View in: PubMed
    Score: 0.002
  65. Hairy cell leukemia: clinical features and therapeutic advances. Cancer Metastasis Rev. 1987; 6(3):283-300.
    View in: PubMed
    Score: 0.002
  66. The effect of cultivation and interferon treatment on the surface morphology of hairy cell leukemia cells. Cancer Invest. 1987; 5(5):389-99.
    View in: PubMed
    Score: 0.002
  67. Hairy cell leukemia and mucormycosis. Treatment with alpha-2 interferon. Am J Med. 1986 Dec; 81(6):1065-7.
    View in: PubMed
    Score: 0.002
  68. A 10-year experience with combined modality therapy for stage III small cell lung carcinoma. Cancer. 1986 Nov 15; 58(10):2177-84.
    View in: PubMed
    Score: 0.002
  69. Postoperative recurrence of lung cancer: detection by whole-body gallium scintigraphy. AJR Am J Roentgenol. 1986 Nov; 147(5):911-5.
    View in: PubMed
    Score: 0.002
  70. Modified stage I (T1N0M0, T2N0M0), nonsmall cell lung cancer: treatment results, recurrence patterns, and adjuvant immunotherapy. Surgery. 1986 Oct; 100(4):621-8.
    View in: PubMed
    Score: 0.002
  71. The role of interferon in the treatment of hairy cell leukemia. Semin Oncol. 1986 Sep; 13(3 Suppl 2):21-8.
    View in: PubMed
    Score: 0.002
  72. Perspective on staging approaches in the malignant lymphomas. Surg Gynecol Obstet. 1986 Aug; 163(2):193-201.
    View in: PubMed
    Score: 0.002
  73. Alpha-2 interferon therapy of hairy-cell leukemia: a multicenter study of 64 patients. J Clin Oncol. 1986 Jun; 4(6):900-5.
    View in: PubMed
    Score: 0.002
  74. Responses of hairy cell leukemia cells to a recombinant alpha-2 interferon in vitro and in vivo: correlation between formation of tubuloreticular structures and clinical parameters. J Biol Response Mod. 1986 Jun; 5(3):270-81.
    View in: PubMed
    Score: 0.002
  75. Disseminated atypical mycobacterial infection in patients with hairy cell leukemia. Am J Med. 1986 May; 80(5):891-6.
    View in: PubMed
    Score: 0.002
  76. Interferons: present and future use in cancer therapy. J Clin Oncol. 1986 Feb; 4(2):123-5.
    View in: PubMed
    Score: 0.002
  77. Local recurrence of resectable non-oat cell carcinoma of the lung. A warning against conservative treatment for N0 and N1 disease. Cancer. 1986 Feb 01; 57(3):471-6.
    View in: PubMed
    Score: 0.002
  78. Sequential treatment of hairy cell leukemia: a new role for interferon. Important Adv Oncol. 1986; 311-21.
    View in: PubMed
    Score: 0.002
  79. Unique scanning electron microscopic features of hairy cells in hairy-cell leukemia. A review and current status. Scan Electron Microsc. 1986; (Pt 4):1515-21.
    View in: PubMed
    Score: 0.002
  80. Prognostic significance of immunologic phenotype in hairy cell leukemia: does it exist? Blood. 1985 Dec; 66(6):1358-61.
    View in: PubMed
    Score: 0.002
  81. Second malignancies in hairy cell leukemia. Cancer. 1985 Sep 15; 56(6):1462-7.
    View in: PubMed
    Score: 0.002
  82. Hairy-cell leukemia associated with Hodgkin's disease: a case report. Am J Hematol. 1985 Apr; 18(4):413-9.
    View in: PubMed
    Score: 0.002
  83. Diagnosis and management of synchronous lung cancers. J Thorac Cardiovasc Surg. 1985 Mar; 89(3):378-85.
    View in: PubMed
    Score: 0.002
  84. In vitro response of cells from three patients with hairy cell leukemia to a recombinant leukocyte interferon. Virchows Arch B Cell Pathol Incl Mol Pathol. 1985; 49(1):73-82.
    View in: PubMed
    Score: 0.002
  85. Autopsy findings in hairy cell leukemia. Semin Oncol. 1984 Dec; 11(4):370-80.
    View in: PubMed
    Score: 0.002
  86. Effect of phorbol ester tumor promoters on hairy cell leukemic cells. Semin Oncol. 1984 Dec; 11(4):433-8.
    View in: PubMed
    Score: 0.002
  87. Chlorambucil therapy of twenty-four postsplenectomy patients with progressive hairy cell leukemia. Semin Oncol. 1984 Dec; 11(4 Suppl 2):502-8.
    View in: PubMed
    Score: 0.002
  88. Treatment of myeloid blastic crisis of chronic myelogenous leukemia. Cancer Treat Rep. 1984 Nov; 68(11):1351-5.
    View in: PubMed
    Score: 0.002
  89. Current concepts in small cell carcinoma of the lung. CA Cancer J Clin. 1984 Sep-Oct; 34(5):269-81.
    View in: PubMed
    Score: 0.002
  90. Infectious complications in 127 patients with hairy cell leukemia. Am J Hematol. 1984 May; 16(4):393-401.
    View in: PubMed
    Score: 0.002
  91. Hypercalcemia and lytic bone lesions in a patient with B-cell non-Hodgkin's lymphoma. N Engl J Med. 1984 Jan 26; 310(4):263-4.
    View in: PubMed
    Score: 0.002
  92. Hairy cell leukemia. Curr Probl Cancer. 1984 Jan; 8(7):1-39.
    View in: PubMed
    Score: 0.002
  93. Hairy cell leukemia: the importance of accurate diagnosis and sequential management. Adv Intern Med. 1984; 29:245-69.
    View in: PubMed
    Score: 0.002
  94. Hairy cell leukemia: a five-year update on seventy-one patients. Ann Intern Med. 1983 Oct; 99(4):485-6.
    View in: PubMed
    Score: 0.002
  95. Hairy cell leukemia: lessons learned in twenty-five years. J Clin Oncol. 1983 Oct; 1(10):652-6.
    View in: PubMed
    Score: 0.002
  96. Lack of efficacy of vinblastine and cisplatin in patients with progressive small cell carcinoma of the lung. Cancer Treat Rep. 1983 Sep; 67(9):831-2.
    View in: PubMed
    Score: 0.002
  97. Cytogenetic studies in patients with hairy cell leukemia. Hematol Oncol. 1983 Jul-Sep; 1(3):215-26.
    View in: PubMed
    Score: 0.002
  98. Non-small cell carcinoma of the lung. Semin Oncol. 1983 Mar; 10(1):1-122.
    View in: PubMed
    Score: 0.002
  99. Chemotherapy of metastatic non-small cell bronchogenic carcinoma. Semin Oncol. 1983 Mar; 10(1):111-22.
    View in: PubMed
    Score: 0.002
  100. Guided biopsies of abnormalities on nuclear bone scans. Technique and indications. J Thorac Cardiovasc Surg. 1983 Mar; 85(3):396-403.
    View in: PubMed
    Score: 0.002
  101. Response to splenectomy in 65 patients with hairy cell leukemia: an evaluation of spleen weight and bone marrow involvement. Blood. 1983 Feb; 61(2):349-52.
    View in: PubMed
    Score: 0.002
  102. Absence of prolonged benefit of initial leukapheresis therapy for hairy cell leukemia. Am J Hematol. 1983 Feb; 14(1):49-56.
    View in: PubMed
    Score: 0.002
  103. Correlation of occupation and karyotype in adults with acute nonlymphocytic leukemia. Blood. 1982 Aug; 60(2):404-11.
    View in: PubMed
    Score: 0.002
  104. Surface immunoglobulins on hairy cells of 55 patients with hairy cell leukemia. Am J Hematol. 1982 Jun; 12(4):397-401.
    View in: PubMed
    Score: 0.002
  105. Treatment of stage IIIA Hodgkin's disease. Cancer Treat Rep. 1982 Apr; 66(4):827-34.
    View in: PubMed
    Score: 0.002
  106. Ultrastructural characterization of de novo and secondary leukemias. Virchows Arch B Cell Pathol Incl Mol Pathol. 1982; 39(3):239-57.
    View in: PubMed
    Score: 0.002
  107. Phagocytic capacity of hairy cells from seventeen patients. Virchows Arch B Cell Pathol Incl Mol Pathol. 1982; 40(3):327-37.
    View in: PubMed
    Score: 0.002
  108. Phospholipid and cholesterol differences amongst leukemic cell types with special reference to hairy cell leukemia: a preliminary report. Clin Chim Acta. 1981 Nov 11; 116(3):311-8.
    View in: PubMed
    Score: 0.002
  109. Significance of cytogenetic abnormalities in acute leukemias. Hum Pathol. 1981 Jun; 12(6):515-22.
    View in: PubMed
    Score: 0.002
  110. Infectious complications associated with hairy cell leukemia. J Infect Dis. 1981 May; 143(5):639-43.
    View in: PubMed
    Score: 0.002
  111. Progress report on chlorambucil therapy in postsplenectomy patients with progressive hairy cell leukemia. Blood. 1981 Mar; 57(3):464-7.
    View in: PubMed
    Score: 0.002
  112. A phase II trial of 9-aminocaptothecin (9-AC) as a 120-h infusion in patients with non-small cell lung cancer. Invest New Drugs. 2001; 19(4):329-33.
    View in: PubMed
    Score: 0.002
  113. Long-term follow-up of remission duration, mortality, and second malignancies in hairy cell leukemia patients treated with pentostatin. Blood. 2000 Nov 01; 96(9):2981-6.
    View in: PubMed
    Score: 0.002
  114. Clinical value of quantitative ventilation-perfusion lung scans in the surgical management of bronchogenic carcinoma. J Thorac Cardiovasc Surg. 1980 Oct; 80(4):535-43.
    View in: PubMed
    Score: 0.002
  115. The treatment of histiocytic lymphoma. Semin Oncol. 1980 Sep; 7(3):302-9.
    View in: PubMed
    Score: 0.002
  116. Non-Hodgkin lymphoma. Introduction. Semin Oncol. 1980 Sep; 7(3):221-2.
    View in: PubMed
    Score: 0.002
  117. Surface immunoglobulin, lectin-induced cap formation, and phagocytic function in five patients with the leukemic phase of hairy cell leukemia. Cancer. 1980 Jul 01; 46(1):50-5.
    View in: PubMed
    Score: 0.002
  118. Diagnosis, staging, and treatment of the malignant lymphomas. Compr Ther. 1980 Jul; 6(7):48-56.
    View in: PubMed
    Score: 0.002
  119. Comparison between the cellular proteins of hairy cell leukemia and the leukemic phase of other lymphoproliferative diseases. Cancer Res. 1980 Jun; 40(6):1907-14.
    View in: PubMed
    Score: 0.002
  120. Importance of substaging of stage III Hodgkin's disease. Semin Oncol. 1980 Jun; 7(2):136-43.
    View in: PubMed
    Score: 0.002
  121. Susceptibility gene for familial acute myeloid leukemia associated with loss of 5q and/or 7q is not localized on the commonly deleted portion of 5q. Genes Chromosomes Cancer. 2000 Jun; 28(2):164-72.
    View in: PubMed
    Score: 0.002
  122. The benefits of open lung biopsy in patients with previous non-diagnostic transbronchial lung biopsy. A guide to appropriate therapy. Chest. 1980 May; 77(5):647-50.
    View in: PubMed
    Score: 0.002
  123. "Microgranular" acute promyelocytic leukemia: a distinct clinical, ultrastructural, and cytogenetic entity. Blood. 1980 Feb; 55(2):253-9.
    View in: PubMed
    Score: 0.002
  124. Ribosome-lamella complex in hairy cell leukemia. Ultrastructure and distribution. Lab Invest. 1980 Feb; 42(2):236-47.
    View in: PubMed
    Score: 0.002
  125. Cytochemistry of hairy cells. Cancer. 1980 Jan 01; 45(1):72-7.
    View in: PubMed
    Score: 0.002
  126. The non-Hodgkin lymphomas. Curr Probl Cancer. 1980 Jan; 4(7):1-35.
    View in: PubMed
    Score: 0.002
  127. Lung cancer: A combined modality approach to staging and therapy. CA Cancer J Clin. 1979 Sep-Oct; 29(5):258-75.
    View in: PubMed
    Score: 0.001
  128. Hairy cell leukemia: effect of 'hairy' cells on normal granulopoiesis in vitro. Exp Hematol. 1979 Sep; 7(8):411-5.
    View in: PubMed
    Score: 0.001
  129. Evolution of karyotypes in acute nonlymphocytic leukemia. Cancer Res. 1979 Sep; 39(9):3619-27.
    View in: PubMed
    Score: 0.001
  130. Neutrophilic leucocyte alkaline phosphatase scores in hairy cell leukaemia: cytochemical, functional, and clinical correlations. Br J Haematol. 1979 Sep; 43(1):156-7.
    View in: PubMed
    Score: 0.001
  131. Fatty acid differences amongst leukemia cell types, with special reference to hairy cell leukemia: a preliminary report. Clin Chim Acta. 1979 Aug 15; 96(1-2):85-90.
    View in: PubMed
    Score: 0.001
  132. Treatment of hairy cell leukemia (leukemic reticuloendotheliosis) II. Chlorambucil therapy in postsplenectomy patients with progressive disease. Blood. 1979 Aug; 54(2):305-9.
    View in: PubMed
    Score: 0.001
  133. Chromosome abnormalities in poorly differentiated lymphocytic lymphoma. Cancer Res. 1979 Aug; 39(8):3119-28.
    View in: PubMed
    Score: 0.001
  134. Splenectomy as initial therapy in twenty-six patients with leukemic reticuloendotheliosis (hairy cell leukemia). Cancer Res. 1979 Jul; 39(7 Pt 1):2366-70.
    View in: PubMed
    Score: 0.001
  135. Small-cell carcinoma of the lung: the prognostic significance of stage on survival. Eur J Cancer (1965). 1979 Jun; 15(6):859-65.
    View in: PubMed
    Score: 0.001
  136. Hairy cell leukemia: differences in phagocytic capacity of cells in vitro. Virchows Arch B Cell Pathol Incl Mol Pathol. 1979 May 04; 30(1):1-13.
    View in: PubMed
    Score: 0.001
  137. Coexistence of leukemic reticuloendotheliosis and histiocytic lymphoma: a case report. Cancer. 1979 May; 43(5):1872-80.
    View in: PubMed
    Score: 0.001
  138. Correction of platelet defect after splenectomy in hairy cell leukemia. JAMA. 1979 Apr 20; 241(16):1684.
    View in: PubMed
    Score: 0.001
  139. Hairy cell leukemia: an autopsy study. Cancer. 1979 Apr; 43(4):1339-49.
    View in: PubMed
    Score: 0.001
  140. Gallium 67 scans in small cell carcinoma. JAMA. 1979 Mar 16; 241(11):1106.
    View in: PubMed
    Score: 0.001
  141. Banding studies of chromosomal abnormalities in patients with acute lymphocytic leukemia. Cancer Res. 1979 Jan; 39(1):227-38.
    View in: PubMed
    Score: 0.001
  142. Metastatic non-oat-cell bronchogenic carcinoma. Therapy with cyclophosphamide, doxorubicin, methotrexate, and procarbazine (CAMP). JAMA. 1978 Dec 15; 240(25):2743-6.
    View in: PubMed
    Score: 0.001
  143. Hairy cell leukemia: an analysis of the chromosomes of 26 patients. Virchows Arch B Cell Pathol. 1978 Nov 17; 29(1-2):113-20.
    View in: PubMed
    Score: 0.001
  144. Clinical implications of chromosome abnormalities in acute non-lymphocytic leukemia: current status. Virchows Arch B Cell Pathol. 1978 Nov 17; 29(1-2):73-9.
    View in: PubMed
    Score: 0.001
  145. Disseminated atypical mycobacterial infection in hairy-cell leukaemia. Lancet. 1978 Nov 11; 2(8098):1052-3.
    View in: PubMed
    Score: 0.001
  146. Hairy cell leukemia: a clinical review based on 71 cases. Ann Intern Med. 1978 Nov; 89(5 Pt 1):677-83.
    View in: PubMed
    Score: 0.001
  147. Correlation of clinical findings with quinacrine-banded chromosomes in 90 adults with acute nonlymphocytic leukemia: an eight-year study (1970-1977). N Engl J Med. 1978 Sep 21; 299(12):613-9.
    View in: PubMed
    Score: 0.001
  148. Hairy cell leukemia: diagnosis and management. CA Cancer J Clin. 1978 Sep-Oct; 28(5):265-77.
    View in: PubMed
    Score: 0.001
  149. Hairy cell leukemia: an unusual lymphoproliferative disease: a study of 24 patients. Cancer. 1978 Aug; 42(2 Suppl):946-56.
    View in: PubMed
    Score: 0.001
  150. Small-cell carcinoma of the lung. Ann Intern Med. 1978 Jul; 89(1):139.
    View in: PubMed
    Score: 0.001
  151. Phase I study of vinorelbine, cisplatin, and concomitant thoracic radiation in the treatment of advanced chest malignancies. J Clin Oncol. 1998 Jun; 16(6):2157-63.
    View in: PubMed
    Score: 0.001
  152. A phase I-II study of paclitaxel, ifosfamide, and vinorelbine with filgrastim (rhG-CSF) support in advanced non-small-cell lung cancer. Ann Oncol. 1998 Jun; 9(6):677-80.
    View in: PubMed
    Score: 0.001
  153. Hexamethylmelamine, bleomycin, and CCNU chemotherapy for patients with squamous cell carcinoma, large cell carcinoma, and adenocarcinoma of the lung unresponsive to cyclophosphamide, adriamycin, methotrexate, and procarbazine. Cancer Treat Rep. 1978 Apr; 62(4):567-9.
    View in: PubMed
    Score: 0.001
  154. Chromosome abnormalities in patients with hairy cell leukemia. Cancer. 1978 Apr; 41(4):1374-80.
    View in: PubMed
    Score: 0.001
  155. Combined modality therapy for stage IIIMO non-oat cell bronchogenic carcinoma. Cancer Treat Rep. 1978 Mar; 62(3):327-32.
    View in: PubMed
    Score: 0.001
  156. Clinicopathologic correlations demonstrating the failure of 67gallium scanning in determining response to radiotherapy. Chest. 1978 Mar; 73(3):356-9.
    View in: PubMed
    Score: 0.001
  157. Hairy cell leukaemia: evidence for the existence of a spectrum of functional characteristics. Br J Haematol. 1978 Feb; 38(2):161-70.
    View in: PubMed
    Score: 0.001
  158. A review of ifosfamide and vinorelbine in advanced non-small cell carcinoma of the lung. Semin Oncol. 1998 Feb; 25(1 Suppl 2):8-14.
    View in: PubMed
    Score: 0.001
  159. Phase I study of docetaxel with concomitant thoracic radiation therapy. J Clin Oncol. 1998 Jan; 16(1):159-64.
    View in: PubMed
    Score: 0.001
  160. Monitoring normal and malignant human white blood cells by the use of linear programmed thermal degradation mass spectrometry. Biomed Mass Spectrom. 1978 Jan; 5(1):47-51.
    View in: PubMed
    Score: 0.001
  161. Megaloblastic anemia during pregnancy. J Reprod Med. 1977 Oct; 19(4):186-92.
    View in: PubMed
    Score: 0.001
  162. Phase I study of vinorelbine and ifosfamide in advanced non-small-cell lung cancer. J Clin Oncol. 1997 Mar; 15(3):884-92.
    View in: PubMed
    Score: 0.001
  163. Hairy-cell leukaemia. Lancet. 1977 Feb 12; 1(8007):372-3.
    View in: PubMed
    Score: 0.001
  164. Adriamycin-radiotherapy interaction. Ann Intern Med. 1977 Jan; 86(1):117.
    View in: PubMed
    Score: 0.001
  165. Oncology and the reproductive years: an invitational symposium. J Reprod Med. 1976 Oct; 17(4):189-90.
    View in: PubMed
    Score: 0.001
  166. An approach to general oncology: principles and procedures. J Reprod Med. 1976 Oct; 17(4):191-7.
    View in: PubMed
    Score: 0.001
  167. Cyclophosphamide, adriamycin, methotrexate, and procarbazine (CAMP)--effective four-drug combination chemotherapy for metastatic non-oat cell bronchogenic carcinoma. Cancer Treat Rep. 1976 Sep; 60(9):1225-30.
    View in: PubMed
    Score: 0.001
  168. Malignant pleural effusion as complication of chronic lymphocytic leukaemia. Lancet. 1976 Aug 21; 2(7982):414-5.
    View in: PubMed
    Score: 0.001
  169. Letter: Hairy cells of leukaemic reticuloendotheliosis. Lancet. 1976 Jul 03; 2(7975):39.
    View in: PubMed
    Score: 0.001
  170. Acute nonlymphocytic leukemia in adults: correlations with Q-banded chromosomes. Blood. 1976 Jul; 48(1):9-21.
    View in: PubMed
    Score: 0.001
  171. Partial deletion of long arm of chromosome 17: a specific abnormality in acute promyelocytic leukemia? Arch Intern Med. 1976 Jul; 136(7):825-8.
    View in: PubMed
    Score: 0.001
  172. Human chromatin and chromosomes studied by scanning electron microscopy: progress and perspectives. J Reprod Med. 1976 Jul; 17(1):29-35.
    View in: PubMed
    Score: 0.001
  173. Ifosfamide-based combination chemotherapy in advanced non-small cell lung cancer: two phase I studies. Semin Oncol. 1996 Jun; 23(3 Suppl 6):11-5.
    View in: PubMed
    Score: 0.001
  174. Ifosfamide-based chemotherapy for non-small cell lung cancer: phase I/II studies at the University of Chicago. Semin Oncol. 1996 Jun; 23(3 Suppl 7):15-8.
    View in: PubMed
    Score: 0.001
  175. Preliminary report on a phase I study of ifosfamide and vinorelbine (navelbine) in advanced non-small cell lung cancer. Semin Oncol. 1996 Apr; 23(2 Suppl 5):11-8.
    View in: PubMed
    Score: 0.001
  176. Ifosfamide plus paclitaxel in advanced non-small-cell lung cancer: a phase I study. Ann Oncol. 1996 Mar; 7(3):314-6.
    View in: PubMed
    Score: 0.001
  177. Human cord blood lymphocytes. Ultrastructural and immunologic surface marker characteristics; a comparison with B- and T-cell lymphomas. Lab Invest. 1976 Feb; 34(2):207-15.
    View in: PubMed
    Score: 0.001
  178. A phase I-phase II study of vinorelbine with cisplatin, 5-fluorouracil, and leucovorin for advanced non-small cell lung cancer. Cancer J Sci Am. 1995 Nov-Dec; 1(4):288-94.
    View in: PubMed
    Score: 0.001
  179. Paclitaxel and ifosfamide: a multicenter phase I study in advanced non-small cell lung cancer. Semin Oncol. 1995 Aug; 22(4 Suppl 9):38-41.
    View in: PubMed
    Score: 0.001
  180. Estrogen receptor. Therapeutic guide in undifferentiated metastatic carcinoma in women. Arch Intern Med. 1975 Jul; 135(7):942-5.
    View in: PubMed
    Score: 0.001
  181. Recombinant alpha-2b-interferon in therapy of previously untreated hairy cell leukemia: long-term follow-up results of study by Cancer and Leukemia Group B. Leukemia. 1995 Jul; 9(7):1116-20.
    View in: PubMed
    Score: 0.001
  182. Dose intensification--a phase I study of ifosfamide with vinorelbine (Navelbine): rationale and study design in advanced non-small cell lung cancer. Semin Oncol. 1995 Apr; 22(2 Suppl 5):30-7; discussion 41-4.
    View in: PubMed
    Score: 0.001
  183. Letter: Surface ultrastructural changes of lymphoid cells in chronic lymphocytic leukaemia. Lancet. 1975 Mar 22; 1(7908):687-8.
    View in: PubMed
    Score: 0.001
  184. 'Hairy' cell leukaemia (leukaemic reticuloendotheliosis): a scanning electron microscopic study of eight cases. Br J Haematol. 1975 Mar; 29(3):455-60.
    View in: PubMed
    Score: 0.001
  185. Cervical synovial sarcoma at the bifurcation of the carotid artery. Cancer. 1975 Feb; 35(2):483-9.
    View in: PubMed
    Score: 0.001
  186. The Sézary syndrome cell: surface ultrastructural characteristics. Acta Haematol. 1975; 54(2):106-14.
    View in: PubMed
    Score: 0.001
  187. Letter: Scanning electron microscopy of hairy cells in hairy-cell leukaemia. Lancet. 1974 Oct 26; 2(7887):1013-4.
    View in: PubMed
    Score: 0.001
  188. Cytogenetic and linkage studies of a familial 15pplus variant. Am J Hum Genet. 1974 Sep; 26(5):535-48.
    View in: PubMed
    Score: 0.001
  189. Increased incidence of second neoplasms in patients treated with interferon alpha 2b for hairy cell leukemia: a clinicopathologic assessment. Blood. 1994 May 15; 83(10):2931-8.
    View in: PubMed
    Score: 0.001
  190. Letter: Human interphase chromatin: a three-dimensional presentation. Lancet. 1974 Apr 27; 1(7861):806-7.
    View in: PubMed
    Score: 0.001
  191. Correlation of the fluorescent banding pattern and ultrastructure of a human chromosome. Exp Cell Res. 1974 Mar 15; 84(1):121-6.
    View in: PubMed
    Score: 0.001
  192. Human chromatin from interphase to metaphase: a scanning electron microscopic study. Exp Cell Res. 1974 Mar 15; 84(1):79-87.
    View in: PubMed
    Score: 0.001
  193. The non-Hodgkin's lymphomas: a review. Rev Bras Pesqui Med Biol. 1974 Mar-Apr; 7(2):123-31.
    View in: PubMed
    Score: 0.001
  194. Constancy of a 200 å fiber in human chromatin and chromosomes. Chromosoma. 1974; 46(3):247-54.
    View in: PubMed
    Score: 0.001
  195. Electron microscopy of human interphase nuclei. Determination of total dry mass and DNA-packing ratio. Chromosoma. 1974; 46(3):233-45.
    View in: PubMed
    Score: 0.001
  196. Interchromosomal fibres: authentic or artefactual? Lancet. 1973 Feb 03; 1(7797):260.
    View in: PubMed
    Score: 0.001
  197. Expression of the IFN alpha receptor in hairy cell leukaemia. Br J Haematol. 1992 Nov; 82(3):541-6.
    View in: PubMed
    Score: 0.001
  198. Ultrastructural characteristics of the spleen in hairy cell leukemia. Leuk Lymphoma. 1992 Sep; 8(1-2):137-42.
    View in: PubMed
    Score: 0.001
  199. Analysis of an isolated metaphase plate by quantitative electron microscopy. Exp Cell Res. 1971 Sep; 68(1):65-74.
    View in: PubMed
    Score: 0.001
  200. Analysis of human chromosomal variants by quantitative electron microscopy. I. Group D chromosome with giant satellites. Genetics. 1971 Sep; 69(1):123-8.
    View in: PubMed
    Score: 0.001
  201. Multicenter clinical trial of mitoxantrone in non-Hodgkin's lymphoma and Hodgkin's disease. J Clin Oncol. 1991 May; 9(5):754-61.
    View in: PubMed
    Score: 0.001
  202. Karyotyping of single human chromosomes from dry mass determined by electron microscopy. Proc Natl Acad Sci U S A. 1971 Apr; 68(4):726-30.
    View in: PubMed
    Score: 0.001
  203. A phase I study of cisplatin, 5-fluorouracil and leucovorin with escalating doses of hydroxyurea in chemotherapy naive patients. Eur J Cancer. 1991; 27(2):217-8.
    View in: PubMed
    Score: 0.001
  204. Analysis of human chromosomal variants by quantitative electron microscopy. II. Ring chromosome 18. Chromosoma. 1971; 34(1):94-8.
    View in: PubMed
    Score: 0.001
  205. Complex rearrangement of the T cell receptor in large granular lymphocytosis associated with myeloid suppression. Leukemia. 1990 Dec; 4(12):863-5.
    View in: PubMed
    Score: 0.001
  206. Is pelvic irradiation necessary in stage III1A Hodgkin's disease? Int J Radiat Oncol Biol Phys. 1990 Sep; 19(3):715-9.
    View in: PubMed
    Score: 0.001
  207. Peripheral blood-derived stem cell collections for use in autologous transplantation after high dose chemotherapy: an alternative approach. Bone Marrow Transplant. 1990 Feb; 5(2):129-33.
    View in: PubMed
    Score: 0.001
  208. The patterns of failure in patients with pathological stage I and II diffuse histiocytic lymphoma treated with radiation therapy alone. Int J Radiat Oncol Biol Phys. 1989 Oct; 17(4):767-71.
    View in: PubMed
    Score: 0.001
  209. Radiation therapy for pathologic stage III Hodgkin's disease with and without chemotherapy. Int J Radiat Oncol Biol Phys. 1989 Oct; 17(4):761-6.
    View in: PubMed
    Score: 0.001
  210. Six-year follow-up of the clinical significance of karyotype in acute lymphoblastic leukemia. Cancer Genet Cytogenet. 1989 Jul 15; 40(2):171-85.
    View in: PubMed
    Score: 0.001
  211. The clinical significance of karyotype in acute myelogenous leukemia. Cancer Genet Cytogenet. 1989 Jul 15; 40(2):203-16.
    View in: PubMed
    Score: 0.001
  212. Rapid dot blot quantitation of viral DNA and amplified genes in less than 1,000 human cells. DNA. 1989 Jun; 8(5):361-7.
    View in: PubMed
    Score: 0.001
  213. Cost-benefit analysis of interferon alfa-2b in treatment of hairy cell leukemia. J Natl Cancer Inst. 1989 Apr 19; 81(8):594-602.
    View in: PubMed
    Score: 0.001
  214. Heat shock proteins in normal and leukemic blood cells. J Interferon Res. 1989 Apr; 9(2):195-204.
    View in: PubMed
    Score: 0.001
  215. Relapse after interferon alfa-2b therapy for hairy-cell leukemia: analysis of prognostic variables. J Clin Oncol. 1988 Nov; 6(11):1714-21.
    View in: PubMed
    Score: 0.001
  216. B-lymphocytic hairy cells contain no HTLV-II DNA sequences. Blood. 1988 Oct; 72(4):1428-30.
    View in: PubMed
    Score: 0.001
  217. Extended mantle radiation therapy for pathologic stage I and II Hodgkin's disease. J Clin Oncol. 1988 Jun; 6(6):1047-52.
    View in: PubMed
    Score: 0.001
  218. Adenosquamous lung carcinoma: clinical characteristics, treatment, and prognosis. Ann Thorac Surg. 1987 Nov; 44(5):462-6.
    View in: PubMed
    Score: 0.001
  219. Use and prognostic value of staging mediastinoscopy in non-small-cell lung cancer. Surgery. 1987 Oct; 102(4):652-9.
    View in: PubMed
    Score: 0.001
  220. Different proteins are induced by alpha- and gamma-interferon in hairy cell leukemia. J Biol Response Mod. 1987 Jun; 6(3):268-74.
    View in: PubMed
    Score: 0.001
  221. In vivo induction of proteins during therapy of hairy cell leukemia with alpha-interferon. Blood. 1987 Jun; 69(6):1570-3.
    View in: PubMed
    Score: 0.001
  222. Action of interferons in hairy cell leukemia. Leukemia. 1987 Apr; 1(4):365-9.
    View in: PubMed
    Score: 0.001
  223. Changes in peripheral blood and bone marrow specimens during and after alpha 2b-interferon therapy for hairy cell leukemia. Leukemia. 1987 Apr; 1(4):340-3.
    View in: PubMed
    Score: 0.001
  224. Associations between morphology, karyotype, and clinical features in myeloid leukemias. Hum Pathol. 1987 Mar; 18(3):211-25.
    View in: PubMed
    Score: 0.001
  225. Durability of responses to interferon alfa-2b in advanced hairy cell leukemia. Blood. 1987 Mar; 69(3):872-7.
    View in: PubMed
    Score: 0.001
  226. Pleuroperitoneal shunting for malignant pleural effusions. Cancer. 1986 Dec 15; 58(12):2740-3.
    View in: PubMed
    Score: 0.001
  227. In vitro induction of proteins by alpha-interferon in hairy cell leukemia. Cancer Res. 1986 Aug; 46(8):4151-5.
    View in: PubMed
    Score: 0.001
  228. Pleural involvement in stage IIIM0 non-small-cell bronchogenic carcinoma. A need to differentiate subtypes. Am J Clin Oncol. 1986 Jun; 9(3):255-61.
    View in: PubMed
    Score: 0.001
  229. Regional accuracy of computed tomography of the mediastinum in staging of lung cancer. J Thorac Cardiovasc Surg. 1986 Apr; 91(4):498-504.
    View in: PubMed
    Score: 0.001
  230. The role of adjuvant therapy after resection of T1 N1 M0 and T2 N1 M0 non-small cell lung cancer. J Thorac Cardiovasc Surg. 1986 Mar; 91(3):344-9.
    View in: PubMed
    Score: 0.001
  231. Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7. J Clin Oncol. 1986 Mar; 4(3):325-45.
    View in: PubMed
    Score: 0.001
  232. Changes in peripheral blood and bone marrow specimens following therapy with recombinant alpha 2 interferon for hairy cell leukemia. Am J Clin Pathol. 1986 Feb; 85(2):194-201.
    View in: PubMed
    Score: 0.001
  233. Topical modes in the preparation of human spleen specimens for routine scanning electron microscopy studies. Scan Electron Microsc. 1986; (Pt 3):1039-50.
    View in: PubMed
    Score: 0.001
  234. Protochemotherapy in non-small cell lung carcinoma. An attempt to increase surgical resectability and survival. A preliminary report. Cancer. 1986 Jan 01; 57(1):44-53.
    View in: PubMed
    Score: 0.001
  235. Treatment of diffuse histiocytic lymphoma (DHL) with COMLA (cyclophosphamide, oncovin, methotrexate, leucovorin, cytosine arabinoside): a 10-year experience in a single institution. J Clin Oncol. 1985 Dec; 3(12):1596-604.
    View in: PubMed
    Score: 0.001
  236. CAMP chemotherapy for metastatic non-oat cell bronchogenic carcinoma. A 7-year experience (1975-1981) with 160 patients. Cancer. 1985 Nov 15; 56(10):2385-90.
    View in: PubMed
    Score: 0.001
  237. Large cell carcinoma of the lung. Ultrastructural differentiation and clinicopathologic correlations. Cancer. 1985 Oct 01; 56(7):1618-23.
    View in: PubMed
    Score: 0.001
  238. Long-term survival of patients with localized diffuse histiocytic lymphoma. J Clin Oncol. 1985 Oct; 3(10):1309-17.
    View in: PubMed
    Score: 0.001
  239. Malignant superior vena cava obstruction reconsidered: the role of diagnostic surgical intervention. Ann Thorac Surg. 1985 Sep; 40(3):285-8.
    View in: PubMed
    Score: 0.001
  240. Pathologic stages IA and IIA Hodgkin's disease: results of treatment with radiotherapy alone (1968-1980). J Clin Oncol. 1985 Jun; 3(6):758-68.
    View in: PubMed
    Score: 0.001
  241. A case-control inquiry into the etiology of hairy cell leukemia. Am J Epidemiol. 1985 May; 121(5):675-83.
    View in: PubMed
    Score: 0.001
  242. Treatment of hairy cell leukemia with recombinant alpha 2 interferon. Blood. 1985 Mar; 65(3):644-8.
    View in: PubMed
    Score: 0.001
  243. Hairy cell leukemia: reevaluation of cell surface features under the scanning electron microscope, using the "GTGO" air drying and critical point drying procedures. Scan Electron Microsc. 1985; (Pt 4):1665-78.
    View in: PubMed
    Score: 0.001
  244. Rapid morphological and substratum adherence response by hairy cell and other human leukemic cells to phorbol ester tumor promoters. Leuk Res. 1985; 9(2):297-304.
    View in: PubMed
    Score: 0.001
  245. Phorbol ester tumor promoters specifically stimulate choline phospholipid metabolism in human leukemic cells. Biochim Biophys Acta. 1984 Dec 06; 796(3):384-92.
    View in: PubMed
    Score: 0.001
  246. Biochemical studies on hairy cell leukemic cells. Semin Oncol. 1984 Dec; 11(4):416-21.
    View in: PubMed
    Score: 0.001
  247. Combined modality therapy for Stage IIIMO non-small cell lung cancer. A five-year experience. Cancer. 1984 Jul 01; 54(1):5-12.
    View in: PubMed
    Score: 0.001
  248. A morphologic and cytochemical study of acute myelomonocytic leukemia with abnormal marrow eosinophils associated with inv(16)(p13q22). Am J Clin Pathol. 1984 Jun; 81(6):733-41.
    View in: PubMed
    Score: 0.001
  249. Evidence for a 15;17 translocation in every patient with acute promyelocytic leukemia. Am J Med. 1984 May; 76(5):827-41.
    View in: PubMed
    Score: 0.001
  250. OCCUPATIONAL STIGMATA. REPORT OF A CASE OF PRONOUNCED FORMATION OF CALLUS ON FINGER TIPS, AMONG OTHER CHARACTERISTIC EFFECTS, IN A VIOLA PLAYER. Arch Dermatol. 1964 Mar; 89:468-70.
    View in: PubMed
    Score: 0.001
  251. Trial of vindesine, etoposide, and cisplatin in patients with previously treated, advanced-stage, non-small cell bronchogenic carcinoma. Cancer Treat Rep. 1984 Feb; 68(2):413-5.
    View in: PubMed
    Score: 0.000
  252. The use of serum albumin for further classification of Stage III non-oat cell lung cancer and its therapeutic implications. Ann Thorac Surg. 1984 Feb; 37(2):115-22.
    View in: PubMed
    Score: 0.000
  253. Initial alkylating agent chemotherapy in a leukemic hairy cell patient. Am J Hematol. 1984 Jan; 16(1):91-4.
    View in: PubMed
    Score: 0.000
  254. Mitoxantrone in malignant lymphomas. Cancer Treat Rev. 1983 Dec; 10 Suppl B:69-72.
    View in: PubMed
    Score: 0.000
  255. The predictive value of initial cytogenetic studies in 148 adults with acute nonlymphocytic leukemia: a 12-year study (1970-1982). Cancer Genet Cytogenet. 1983 Nov; 10(3):219-36.
    View in: PubMed
    Score: 0.000
  256. Association of an inversion of chromosome 16 with abnormal marrow eosinophils in acute myelomonocytic leukemia. A unique cytogenetic-clinicopathological association. N Engl J Med. 1983 Sep 15; 309(11):630-6.
    View in: PubMed
    Score: 0.000
  257. Treatment of modified Stage II (T1 N1 M0, T2 N1 M0) non-small cell bronchogenic carcinoma. A combined modality approach. J Thorac Cardiovasc Surg. 1983 Aug; 86(2):180-5.
    View in: PubMed
    Score: 0.000
  258. Morphologic and cytochemical observations on the overt leukemic phase of therapy-related leukemia. Am J Clin Pathol. 1983 May; 79(5):525-30.
    View in: PubMed
    Score: 0.000
  259. Development of dysmyelopoietic syndrome in a hairy cell leukemia patient treated with chlorambucil: cytogenetic and morphologic evaluation. Cancer Genet Cytogenet. 1983 Feb; 8(2):107-15.
    View in: PubMed
    Score: 0.000
  260. Metastatic non-small cell bronchogenic carcinoma: a randomized trial of sequential vs combination chemotherapy. Eur J Cancer Clin Oncol. 1983 Jan; 19(1):33-8.
    View in: PubMed
    Score: 0.000
  261. Increased cholesterol biosynthesis in leukemic cells from patients with hairy cell leukemia. Blood. 1983 Jan; 61(1):50-60.
    View in: PubMed
    Score: 0.000
  262. Histiocytic lymphoma: response to chemotherapy. Ann Intern Med. 1982 Oct; 97(4):617-8.
    View in: PubMed
    Score: 0.000
  263. Unique cell surface glycoprotein expression in hairy cell leukemia: effect of phorbol ester tumor promoters on surface glycoproteins, cell morphology, and adherence. Cancer Res. 1982 Sep; 42(9):3724-8.
    View in: PubMed
    Score: 0.000
  264. Response to 5-azacytidine in patients with refractory acute nonlymphocytic leukemia and association with chromosome findings. Cancer. 1982 Jun 01; 49(11):2222-5.
    View in: PubMed
    Score: 0.000
  265. Prognostic factors in patients with non-small cell bronchogenic carcinoma and brain metastases. Cancer. 1982 May 01; 49(9):1916-9.
    View in: PubMed
    Score: 0.000
  266. Bronchogenic carcinoma located in the aortic window. The importance of the primary lesion as a determinant of survival. J Thorac Cardiovasc Surg. 1982 Apr; 83(4):551-62.
    View in: PubMed
    Score: 0.000
  267. VP16-213 in combined modality treatment of small cell carcinoma of the lung. Eur J Cancer Clin Oncol. 1982 Apr; 18(4):343-6.
    View in: PubMed
    Score: 0.000
  268. Prognostic significance of posttransfusion hepatitis and chromosomal abnormalities in adult acute nonlymphocytic leukemia. Cancer Genet Cytogenet. 1982 Apr; 5(4):281-92.
    View in: PubMed
    Score: 0.000
  269. Anatomic substages of stage IIIA Hodgkin's disease: followup of a collaborative study. Cancer Treat Rep. 1982 Apr; 66(4):733-41.
    View in: PubMed
    Score: 0.000
  270. Survival of patients with localized diffuse histiocytic lymphoma. Blood. 1981 Dec; 58(6):1218-23.
    View in: PubMed
    Score: 0.000
  271. Hairy cell leukemia in father and son. Cancer. 1981 Oct 15; 48(8):1825-9.
    View in: PubMed
    Score: 0.000
  272. Nonrandom chromosome abnormalities in acute leukemia and dysmyelopoietic syndromes in patients with previously treated malignant disease. Blood. 1981 Oct; 58(4):759-67.
    View in: PubMed
    Score: 0.000
  273. Hairy cell leukemia: association with disseminated atypical mycobacterial infection. Cancer. 1981 Jul 15; 48(2):380-3.
    View in: PubMed
    Score: 0.000
  274. Chromosome changes in hematologic malignancies. CA Cancer J Clin. 1981 Jul-Aug; 31(4):222-38.
    View in: PubMed
    Score: 0.000
  275. Lymphoblastic lymphoma in adults. Cancer. 1981 May 15; 47(10):2510-6.
    View in: PubMed
    Score: 0.000
  276. Diffuse histiocytic lymphoma with sclerosis: a clinicopathologic entity frequently causing superior venacaval obstruction. Cancer. 1981 Feb 15; 47(4):748-56.
    View in: PubMed
    Score: 0.000
  277. Prognostic significance of immunological tests in lung cancer. Clin Exp Immunol. 1981 Feb; 43(2):362-9.
    View in: PubMed
    Score: 0.000
  278. Late relapses in Hodgkin disease. Am J Hematol. 1981; 10(1):31-6.
    View in: PubMed
    Score: 0.000
  279. Small-cell carcinoma of the lung: a five-year experience with combined modality therapy. Cancer. 1980 Dec 15; 46(12):2550-6.
    View in: PubMed
    Score: 0.000
  280. Cyclophosphamide, vincristine, methotrexate with leucovorin rescue, and cytarabine (COMLA) combination sequential chemotherapy for advanced diffuse histiocytic lymphoma. Ann Intern Med. 1980 Jun; 92(6):785-90.
    View in: PubMed
    Score: 0.000
  281. Dysmyelopoietic syndrome: sequential clinical and cytogenetic studies. Blood. 1980 Apr; 55(4):636-44.
    View in: PubMed
    Score: 0.000
  282. Anatomic substages of stage III-A Hodgkin's disease. A collaborative study. Ann Intern Med. 1980 Feb; 92(2 Pt 1):159-65.
    View in: PubMed
    Score: 0.000
  283. Chromosomes and causation of human cancer and leukemia. XXXV. The missing Y in acute non-lymphocytic leukemia (ANLL). Cancer. 1980 Jan 01; 45(1):84-90.
    View in: PubMed
    Score: 0.000
  284. Sequential staging in bronchogenic carcinoma. Chest. 1979 Dec; 76(6):653-7.
    View in: PubMed
    Score: 0.000
  285. Chromosome analysis of primary large bowel tumors: a new method for improving the yield of analyzable metaphases. Cancer. 1979 Nov; 44(5):1656-64.
    View in: PubMed
    Score: 0.000
  286. Pathologic stage I and II Hodgkin's disease, 1968--1975: relapse and results of retreatment. Cancer. 1979 Jul; 44(1):72-9.
    View in: PubMed
    Score: 0.000
  287. The relationship between immune reactivity, serum cortisol, and stage of disease in patients with non-oat-cell bronchogenic carcinoma. Surgery. 1979 Jul; 86(1):130-7.
    View in: PubMed
    Score: 0.000
  288. Evolution of karyotypes in Philadelphia (Ph1) chromosome-negative chronic myelogenous leukemia. Cancer. 1979 Feb; 43(2):411-6.
    View in: PubMed
    Score: 0.000
  289. B cell acute lymphoblastic leukemia (ALL) with a 14q+ chromosome abnormality. Blood. 1979 Feb; 53(2):235-43.
    View in: PubMed
    Score: 0.000
  290. Scintigraphic evaluation of sarcomata in children and adults by Ga67 citrate. Cancer. 1978 Oct; 42(4):1760-5.
    View in: PubMed
    Score: 0.000
  291. Hypergranular promyelocytic leukemia (APL): cytogenetic and ultrastructural specificity. Blood. 1978 Aug; 52(2):272-80.
    View in: PubMed
    Score: 0.000
  292. Acute nonlymphocytic leukemia in malignant lymphoma: a morphologic study. Cancer. 1978 Jul; 42(1):229-42.
    View in: PubMed
    Score: 0.000
  293. Non-Hodgkin's lymphoma, poorly differentiated lymphocytic and mixed cell types: results of sequential staging procedures, response to therapy, and survival of 100 patients. Cancer. 1978 Jul; 42(1):88-95.
    View in: PubMed
    Score: 0.000
  294. A chromosome marker for B-cell cancers. N Engl J Med. 1978 06 22; 298(25):1422.
    View in: PubMed
    Score: 0.000
  295. The leukemic phase of histiocytic lymphoma. Histologic, cytologic, cytochemical, ultrastructural, immunologic and cytogenetic observations in a case. Am J Clin Pathol. 1978 May; 69(5):550-8.
    View in: PubMed
    Score: 0.000
  296. Sepsis in treated Hodgkin's disease. Am J Med. 1978 May; 64(5):914-5.
    View in: PubMed
    Score: 0.000
  297. Central nervous system involvement in patients with histiocytic lymphoma, diffuse type. Blood. 1978 Jan; 51(1):177-9.
    View in: PubMed
    Score: 0.000
  298. Further evidence for a non-random chromosomal abnormality in acute promyelocytic leukemia. Int J Cancer. 1977 Dec 15; 20(6):869-72.
    View in: PubMed
    Score: 0.000
  299. Chromosomal aneuploidy in a patient with hypereosinophilic syndrome. Evidence for a malignant disease. Am J Med. 1977 Dec; 63(6):1010-4.
    View in: PubMed
    Score: 0.000
  300. Acute leukemia after treatment of lymphoma. N Engl J Med. 1977 Nov 03; 297(18):1013.
    View in: PubMed
    Score: 0.000
  301. Prognostic classification of Hodgkin disease in pathologic stage III, based on anatomic considerations. Blood. 1977 Jun; 49(6):883-93.
    View in: PubMed
    Score: 0.000
  302. 15/17 translocation, a consistent chromosomal change in acute promyelocytic leukaemia. Lancet. 1977 Mar 05; 1(8010):549-50.
    View in: PubMed
    Score: 0.000
  303. Chronic lymphocytic leukaemia and its relationship to other lymphoproliferative disorders. Clin Haematol. 1977 Feb; 6(1):141-57.
    View in: PubMed
    Score: 0.000
  304. The clinical features of chronic lymphocytic leukaemia. Clin Haematol. 1977 Feb; 6(1):185-202.
    View in: PubMed
    Score: 0.000
  305. Survival of patients with localized histiocytic lymphoma. Cancer. 1977 Jan; 39(1):342-6.
    View in: PubMed
    Score: 0.000
  306. Idiopathic acquired refractory sideroblastic anemia: Banded chromosome analysis in six patients. Acta Haematol. 1977; 57(1):15-23.
    View in: PubMed
    Score: 0.000
  307. Gallium-67 scanning for carcinoma of the lung. J Thorac Cardiovasc Surg. 1976 Nov; 72(5):699-708.
    View in: PubMed
    Score: 0.000
  308. Disseminated malignant lymphoma, histiocytic type: the changing picture. Ann Intern Med. 1976 Oct; 85(4):521-3.
    View in: PubMed
    Score: 0.000
  309. Acute monocytic leukemia. Cytologic, histologic, cytochemical, ultrastructural, and cytogenetic observations. Am J Clin Pathol. 1976 Apr; 65(4):471-82.
    View in: PubMed
    Score: 0.000
  310. Letter: Prolonged survival of patients with extensive oat cell carcinoma treated with radiotherapy and cyclophosphamide (NSC-26271), vincristine (NSC-67574), and methotrexate (NSC-7040). Cancer Treat Rep. 1976 Mar; 60(3):221-3.
    View in: PubMed
    Score: 0.000
  311. Bone marrow involvement in non-Hodgkin's lymphoma: implications for staging and therapy. Cancer. 1976 Feb; 37(2):629-36.
    View in: PubMed
    Score: 0.000
  312. Letter: Combined therapy for small-cell carcinoma of the bronchus. Lancet. 1976 Jan 31; 1(7953):248.
    View in: PubMed
    Score: 0.000
  313. Letter: Chemotherapy of advanced histocytic lymphomas. Lancet. 1975 May 17; 1(7916):1136.
    View in: PubMed
    Score: 0.000
  314. Combination chemotherapy of lymphomas other than Hodgkin's disease. Ann Intern Med. 1974 Nov; 81(5):601-8.
    View in: PubMed
    Score: 0.000
  315. Familial neuromuscular disease with "myotubes". Clin Genet. 1974; 5(4):327-37.
    View in: PubMed
    Score: 0.000
  316. Identification of a C6-G21 translocation chromosome by the Q-M and Giemsa banding techniques in a patient with Down's syndrome, with possible assignment of Gm locus. Clin Genet. 1973; 4(1):53-7.
    View in: PubMed
    Score: 0.000
  317. Identification of a D-E(15-18) translocation chromosome by quinacrine fluorescence and urea banding techniques. Humangenetik. 1973; 17(4):317-21.
    View in: PubMed
    Score: 0.000
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.